Labshake search
Citations for Leinco Technologies :
1 - 11 of 11 citations for Integrin alpha 4 Rabbit Recombinant mAb since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2023Quote: ... and treated with recombinant mouse IL-4 (Leinco technologies, Inc. I-207) at a 40ng/ml concentration for 6 hours ...
-
bioRxiv - Immunology 2023Quote: ... allowed to sit for 3 hours and treated with recombinant mouse IL-4 (Leinco technologies, Inc. I-207) for 4 hr ...
-
bioRxiv - Microbiology 2023Quote: ... or 500 µg MP1-22E9 mAb anti-GM-CSF (Leinco Technologies, Inc.) on -1- and 0dpi (47) ...
-
bioRxiv - Microbiology 2023Quote: ... Fc receptors were blocked for 10 minutes with CD32/CD16 mAb (Leinco Technologies, Inc.). Cells were incubated with Zombie UV™ Fixable Viability Dye (BioLegend ...
-
ORAI1 establishes resistance to SARS-CoV-2 infection by regulating tonic type I interferon signalingbioRxiv - Microbiology 2021Quote: ... that for detection of interferon alpha and beta receptor 1 (IFNAR-1) was purchased from Leinco Technologies, Inc ...
-
bioRxiv - Microbiology 2023Quote: ... Mice were injected intraperitoneally (i.p.) with 500 µg of control mAb rat IgG2a (Leinco Technologies, Inc.) or 500 µg MP1-22E9 mAb anti-GM-CSF (Leinco Technologies ...
-
bioRxiv - Systems Biology 2021Quote: ... Recombinant purified N-terminal domain (NTD) of the SARS-CoV-2 was obtained from Leinco Technologies Inc (Cat #S853 ...
-
bioRxiv - Immunology 2022Quote: ... and 100 μg anti CTLA-4 (clone 9D9, Leinco Technologies) in volume of 200 μg 1X PBS.
-
bioRxiv - Cell Biology 2022Quote: ... Goat anti-rabbit HRP secondary antibody (Leinco Technologies, R115); Goat Anti-rabbit Alexa 555 (Invitrogen ...
-
bioRxiv - Immunology 2022Quote: ... Mice were also treated with 4 μg mIFNβ neutralising antibodies (Leinco Technologies Inc). Control groups were treated with either buffer or an IgG isotype control antibody equivalently.
-
bioRxiv - Immunology 2023Quote: ... they were treated with anti-PD-1 anti-CTLA-4 antibodies (clones RMP1-14 and 9H10, respectively, from Leinco Technologies Inc., Fenton, MO, USA): 200 µg ab/injection ...